Company overview

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs.For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.
Münchenstein, Basel-Country, CHE
67% recommend to a friend
61% positive business outlook

Salaries

Help build salary transparency at Lonza

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

7 open now

Funding

Total funding

$444.8M

Last raise

$444.8M

Post IPO Debt, 2 years ago

Funding history

Nov 2023

Post IPO Debt Lonza · $444.8M

Audience

LinkedIn followers

Follower count and growth

Total followers

435.5K

12-mo growth

+20.6%

Monthly growth

+2.6%

News

Links